Bio Hazards Bag Market | BioMedical Waste Solutions, LLC, Clean Harbors Inc., Daniels Sharpsmart Inc., REMONDIS Medison GmbH | By 2032

The Bio Hazards Bag Market is projected to increase at a CAGR of 7%, from a size of US$ 424.36 million in 2022 to a value of US$ 777.50 million by 2032.

Biohazard Waste, also known as infectious or biomedical waste, is any disposed material which contains potentially infectious substances like human bodily fluids, microbiological, pathological, animal waste. Particular care must be given to sharp waste like needles, IV tubes, glass slides etc.

which can injure during handling and cause infections. A bag specially designed to collect or dispose of such material from a crime or accident and take to a laboratory for analysis is a biohazard bag. It prevents contamination of the samples and also keeps the handler of such material safe. These bags are usually of a rugged construction and can have up to three layers of polypropylene or any other plastic polymer.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2171

Bio Hazards Bag Market Drivers

Hospitals account for the largest producers of bio hazardous waste for obvious reasons. Hence it is expected that the bio hazard bag market will record a much higher growth rate in developing than developed countries since they are rapidly building up infrastructure like hospitals to cater to a growing economy.

Additionally, their governments can be reasonably expected to enforce strict hazard disposal norms to ensure the safety and security of their citizens. Along with this, an aging population in the developed world and strict government regulations already in place there will continue to ensure a sustained bio hazard bag market there.

Bio Hazards Bag Market Restraints

The bio hazards bag market growth restraints can primarily be divided into that faced by the developing and developed world. In emerging economies like China, India, Middle East North Africa and Latin America there is a general lack of awareness about safe disposal methods of such potentially life-threating material.

The government norms also tend to be less stringent than that of the Western world, which makes hospitals or pharmaceutical laboratories more likely to not give the hazardous material disposal the undivided attention it deserves.

Even in developed countries, the sheer volume of bio hazardous waste created due to the reasons mentioned above in the report can pose a serious challenge. Advanced economies also sterilize their used bio hazard bags and sell it to developing countries at a much lower cost. This also poses a challenge to manufacturers selling expensive new equipment to those countries.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2171

Bio Hazards Bag Market Key Regions

The bio hazards bag market key regions include North America, Latin America, Eastern Europe, Western Europe, Asia – Pacific, MENA and Japan. North America is the largest bio hazard bag market at present followed by Europe. That’s mainly due to stringent government regulations regarding waste disposal, an aging population and a thereby a large amount of waste generated.

The APAC region will account for a substantial portion of the expected growth of in the medium to long term due to massive populations and the large scale shift from rural to urban areas, leading to increased requirement of efficient waste management systems.

Bio Hazards Bag Market Key Market Players 

Some of the main manufacturers competing in the bio hazards bag market are BioMedical Waste Solutions, LLC (U.S.), Clean Harbors, Inc. (U.S.), Daniels Sharpsmart, Inc. (U.S.), REMONDIS Medison GmbH (Germany), Republic Services, Inc. (U.S.), Sharps Compliance, Inc. (U.S.), Stericycle, Inc. (U.S.), Suez Environnement S.A. (France), Veolia Environnement S.A. (France), and Waste Management, Inc. (U.S.).

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-2171

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Top More Related Reports:

Preventive Medicine Market

Cardiac Rhythm Remote Monitoring Devices Market

Breast Cancer Drug Market

Dialysis Device and Concentrates Market

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse All Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Antibodies Market | Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Amgen Inc. | By 2033

The Antibodies Market is projected to reach US$ 236.9 billion in 2023 and is expected to grow at a CAGR of 13.4% from 2023 to 2033. The market for antibodies is predicted to reach US$ 834.2 Bn by 2033. The global market’s absolute dollar increase represents the entire market value of the antibodies industry at US$ 597.3 Bn.

The Antibodies Market is expected to reach market valuation of US$ 186.865 Billion in 2021. The growth can be attributed to high versatility of antibodies in treating wide array of ailments and high demand for antibody cocktails to treat COVID-19.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1330

Antibodies market is very competitive with F. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services Inc., Amgen Inc., and Bristol-Myers Squibb Company holding around 75% of global market shares as of 2021.

As per the National Institute of Health, autoimmune diseases are more prevalent in women as compared to men and are also the leading cause of death in women under the age 65. Rising incidence of autoimmune diseases like diabetes and scleroderma in women will boost the demand for antibodies in forthcoming years.

The COVID-19 pandemic accelerated the demand for antibody therapeutics as it has been found effective in treating COVID-19 patients that are non hospitalized but are highly susceptible to contracting various other ailments. In some cases COVID-19 triggered the autoimmune diseases in the patient further increasing the demand.

Surge in number of Parkinson’s disease and Alzheimer patients and rising necessity to create affordable antibody therapeutics for population in low income countries will accelerate the market growth.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1330

Increased number of drugs at various phases of clinical trials and rising drug approval rates from concerning authorities will drive the market for antibodies.

However, high cost of biologics is a growing concern as it increases healthcare cost. Rising economic load of cancer and other ailments is accelerating the healthcare spending.

With incorporation of modern production techniques for manufacturing therapeutic antibodies will promote the market penetration in cost sensitive regions like Asian market.

Key Takeaways from FMI’s Antibodies Market Study

  • The U.S. is expected to lead the antibodies market during the assessment period due to presence of leading antibody drugs manufacturers, increased consumer spending on healthcare and rising incidences of autoimmune and other chronic ailments in the country.
  • Rising prevalence of cancer and establishment of modern pharmaceutical and medical research centers in Saudi Arabia will drive the antibodies market growth in the country.
  • China is forecast to exhibit tremendous growth owing to increased government spending on healthcare, heightened production of antibodies therapeutics and growing geriatric population in the country.
  • Rapid technological advancements in healthcare sector, increasing government funding to make the treatment affordable, and increasing consumer spending on healthcare will create opportunities for market growth in India.
  • Rising prevalence of non-Hodgkin lymphoma and other type of cancer along with increasing demand for non invasive treatment options will fuel the demand for cancer antibodies
  • Monoclonal antibodies are forecast to exhibit high demand throughout the forecast period owing to rising drug approval rates and increasing cases of rheumatoid arthritis, psoriasis, and asthma in geriatric population across the globe.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-1330

“Rising effectiveness of antibody cocktails in treating COVID-19 especially in at risk patients will boost the antibodies market growth throughout the forecast period,” says the FMI analyst.

Competitive Landscape

Antibodies market is consolidated as top antibodies producers hold 75% of global market share. New product development is the key area of focus among market players in order to strengthen their market position.

They are also involved in performing extensive research and development for product portfolio expansion. They are also working towards developing cheaper antibody therapeutics to penetrate the new markets and capture maximum market share especially in emerging economies.

Some market players are emphasizing on strategic merger and acquisition and partnership with other market players for rapid roll out of drugs and portfolio expansion. They are also emphasizing towards faster product approvals across various government agencies.

Bristol-Myers Squibb Company entered into an exclusive strategic collaboration with Eisai Co. Ltd. for the co-development and co-commercialization of an antibody-drug complex called “MORAb-202” on 17th June 2021.

In January 2021, Sanofi announced to acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies at around US$ 1.1 Bn. The aim of the acquisition is to focus on developing immune-mediated diseases and immuno-oncology therapeutics.

Prominent players operating in the antibodies market are:-

  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Sanofi SA
  • Eli Lilly and Co.

For Read More Related Insights:

Acetaminophen API Market

Contact-Free Sleep Monitoring Systems Market

Therapeutic Apheresis Market

Clinical Decision Support Market

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse All Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Insulin Pens Market value is forecast to reach US$ 46,906.4 Mn by 2031 | FMI

[200 Pages Report] According to Future Market Insights (FMI), the demand for insulin pens is expected to rise considerably in the coming decade, enabling the market to surpass a valuation of US$ 30,407.5 Mn by the end of 2021.

Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster.

According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential.

Type 2 diabetes cases are common, but it can be prevented or delayed by a healthy diet, consistent physical activity, maintaining a standard body weight and avoiding the use of tobacco. Diabetes can be treated or managed with medicines and regular checking and treatment. Increasing focus on innovative medical products and research are increasingly driving a transition towards insulin pen by diabetes patients.

Leading manufacturers in the insulin pen market are strengthening their market position through collaborations with various health and research organizations. Governments in developed and developing countries are actively taking initiatives to encourage innovative medical products.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13518

For instance, in November 2020, Medtronic introduced CGM integrated smart insulin delivery pen to manage multiple daily dosage insulin injections. Similarly, Insulet expanded its offering of OmipodDASH into additional countries such as Sweden, Finland, Norway, and Denmark.

Key Takeaways from Insulin Pen Services Market Study

  • Reusable insulin pens are expected to account for over 49% the global market share by 2031, supported by a growing base of environment and cost-conscious consumers.
  • Hospital pharmacies will account for 33.8% of the market share in 2031. The soaring influx of patients for treatment and intensive care support supports growth.
  • The U.S. is projected to be the fastest-growing regional market with a CAGR of 5.6% through 2021-2031 owing to the matured healthcare sector of the country.
  • The U.K. and Germany are leading markets in Europe, accounting for more than 18% and 25% in 2021.
  • China is the largest and fastest growing market in East Asia, exhibiting a 4.7% CAGR through 2031.
  • Australia is leading the Oceania market, accounting for more than 85% of insulin pen revenues in 2021.

Who is Winning?

The global insulin pen market is set to expand due to the rising prevalence of type 1 and type 2 diabetes. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-13518

Some of the leading players in the insulin pen market include but are not limited to NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, YpsoMed AG, and DUKADA Aps.

Insulin Pens Market by Category

By Product Type:

  • Reusable Insulin Pen
  • Refillable Pens
  • Bluetooth Connected Smart Insulin Pen
  • USB Connected Smart Insulin Pen
  • Cartridge
  • Disposable Insulin Pens
  • Smart Insulin Pens Caps
  • Insulin Pump

By Indication:

  • Type 1
  • Type 2

Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinic/Center

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Feminine Hygiene Products Market is likely to surpass US$ 54,189.6 Mn by 2031 | FMI

Government initiatives undertaken to spread awareness about women health and menstrual hygiene, besides brand consolidation strategies by leading producers and the adoption of modern lifestyles by women will push feminine hygiene products sales in the coming years.

According to the recent Future Market Insights (FMI) report, the global feminine hygiene products market value is estimated to surpass US$ 27.6 Bn in 2021, with a CAGR of 7.0% during the forecast period (2021-2031).

Around 49% of the global population is female and nearly 65% of them are aged between 15 and 65 years, thereby indicating a significant opportunity for manufacturers of feminine hygiene products.

Government organizations are focusing on women’s health and hygiene with the help of launch of various awareness programs and funding activities. These programs include detailed education about menstruation, puberty, and the advantages and health benefits of using hygiene products.

They are also providing sanitation kits to girls studying in government schools and colleges in rural areas, particularly in developing economies around the globe. For instance, in 2017, the Department of Education in KwaZulu-Natal (KZN) of South Africa set aside Rs 50 million to fund the distribution of sanitary towels and napkins to various schools in the region.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13350

Additionally, rising female populations in countries such as India, Ghana, and Nigeria will create lucrative opportunities. Concerns regarding disposal, have resulted in the introduction of reusable menstrual cups. These cups are made from medical grade silicon or latex and cost between US$ 20 and US$ 50 per pack and can last for nearly five years. Such innovations will give tailwinds to growth registered in the market.

The impact of the ongoing COVID-19 pandemic on production of feminine products has been negligible despite short term disruptions of transportation and logistics.

Key Takeaways from Feminine Hygiene Products Market Study

  • Sanitary napkins are the largest and fastest growing segment accounting for nearly half of the market by 2031, with a CAGR of over 8%.
  • Supermarket are projected to account for over 22% of the global market by 2031. This is attributed to robust supply channels for consumer health products.
  • East Asia is the largest revenue-generating region for feminine hygiene products, with the China accounting for nearly 81% of the regional market in 2021.
  • Germany holds the lead in Europe, and is expected to accounting for over 18% of the market in 2031.
  • South Asia is the second most lucrative market after East Asia with India accounting for over 75% of the value share in 2031.

 Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-13350

Who is Winning?

Some of the leading manufacturers of the feminine hygiene products market are focusing on mergers and acquisitions for global expansion. Thus, enhancing their market presence.

The key market players covered by FMI include Procter and Gamble, Johnson and Johnson, the Kimberly-Clark Corporation, Svenska Cellulosa Aktiebolaget SCA, Sanofi S.A, Lil-lets UK Limited, Ontex, Unicharm Corporation, Diva International Inc., and Edgewell Personal Care.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-13350

Feminine Hygiene Products Market by Category

Product type:

  • Sanitary Napkins
  • Tampons
  • Menstrual Cup
  • Panty liners
  • Feminine Hygiene Wash

Distribution Channel:

  • Hypermarket
  • Supermarket
  • Convenience Stores
  • Department Stores
  • Retail Pharmacies
  • Online Purchase

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Nasal Spray Market is forecast to exhibit impressive growth to reach US$ 27.37 Billion by 2030 | FMI

[250 Pages Report] Future Market Insights (FMI) has forecast positive outlook for the nasal spray market in a recent study. The rising cases of allergic rhinitis and the demand for better accuracy in drug delivery are identified as chief growth drivers. Growth is expected to remain bullish as various countries showcase high healthcare spending.

Nasal Spray Market is expected to expand at a moderate CAGR of over 6.1% over the next ten years, and be valued at more than US$ 3.21 Bn by 2030-end. As per product, the demand for nasal steroid spray will remain considerably high, accounting for the leading share in the market though the course of the forecast period.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13112

According to a study by the Research and Development (RAND) Review blog published in 2017, nearly 60% of Americans have at least one chronic health condition, which often results in accelerating healthcare spending each year. With the incidence of chronic ailments and resultant spending on healthcare projected to spur, nasal sprays market will have positive growth on cards.

As per the report, the market’s overall valuation is likely to surpass US$ 15 Bn by 2021. Growth will continue at a positive rate, thanks to recent approvals to nasal migraine and hormonal therapies.

Among products available, nasal steroid spray will prove exceptionally lucrative, accounting for over 42% of sales in the market. Besides their improving availability, potential to offer relief from nasal allergies and  hay fever will drive growth in the category

Key Players:

  • Astra Zeneca  Plc.
  • Cipla Ltd.
  • Johnson & Johnson Services, Inc. (Johnson & Johnson Pacific Pty Limited)
  • Glaxosmithkline Plc.
  • Novartis International AG
  • Procter & Gamble
  • Sanofi S.A. (Sanofi-aventis LLC.)
  • Boehringer Ingelheim GmbH
  • AdvaCare Pharma
  • Bayer AG (Bayer Consumer Health
  • Covis Pharma S.a.r.l.
  • Nipro Corporation (NIPRO JMI Pharma Ltd.)
  • Viatris Inc. (Meda Pharmaceuticals Inc.)
  • Perrigo Company plc
  • AptarGroup, Inc.
  • Berry Global, Inc.
  • URSATEC GmbH
  • Gerresheimer AG
  • Bona
  • Avantor, VWR International, LLC
  • Spectrum Laboratory Products, Inc.  (Spectrum Pharmacy Products)
  • SKS Bottle & Packaging, Inc.
  • Coster Tecnologie Speciali S.p.A

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-13112

Key Takeaways from Nasal Spray Market Study   

  • Rising at above 6% CAGR between 2021 and 2031, nasal sprays market will report consistent surge in demand
  • The market in the U.S. is projected to a fast-growing one, accounting for more than 90% share in the North America market
  • Government spending on healthcare has created a conducive environment for growth in the U.K.
  • Germany will emerge as a leading market for nasal sprays sales in Europe backed by increasing healthcare spending and presence of leading manufacturers
  • Focus on health and wellness will continue rising in Japan and South Korea, driving nasal spray sales in East Asia

Government Initiatives toward Nasal Spray Consumption

Governmental support for ongoing clinical research, consumption of Nasal Spray, and restricting misuse have favoured growth in demand for Nasal Spray. For instance, there has been a call for rise in production capacity of budesonide nasal spray which shortens COVID19 recovery time.

Since, nasal sprays are also used for depression patients, the market is likely to grow highly.

Who is Winning?

Nasal spray manufacturers with patented drugs are successfully allocating their distribution rights to local companies that are operational in the pain management business. This strategy provides momentum to the growth of these companies’ business, owing to strong demand for generic drugs.

For instance, In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13112

Nasal Spray Market by Category

Product

  • Decongestant Sprays
  • Nasal Steroid Sprays
  • Nasal Antihistamine Sprays
  • Nasal Cromolyn Sodium Sprays
  • Nasal Anticholinergic Sprays
  • Nasal Triamcinolone Sprays

Formulation

  • Aqueous
  • Hydroalcoholic
  • Nonaqueous-Based Solution
  • Suspension
  • Emulsions
  • Dry Powder/Micro particles

Packaging

  • Pressurized Canisters
  • Pump Bottles

 Distribution Channel

  • Institutional Sales
    • Hospitals
    • Community Clinics
    • Specialty Clinics
    • Public Health Agencies
    • Veterinary Hospitals & Clinics
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Mail Order Pharmacy

About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedInTwitterBlogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Compression Therapy Market value of US$ 3.01 Billion in 2022 | FMI

The USD 3 billion compression therapy market is likely to grow witness 6% CAGR through 2030, despite the COVID-19 blip, according to market research firm Future Market Insights. According to a latest study that tracks compression therapy adoption and market analysis in 20+ countries, the long-term outlook remains optimistic.

Highlighting the key influencing factors, the study opines that growing diabetic population across the globe has increased the demand for compression stockings and diabetic socks. Moreover, innovations like NPWT (Negative Pressure Wound Therapy) have turned out to be the modus operandi for managing acute and chronic wounds. Also, advancements in pneumatic compression therapy have proven to be effective and safe in treating lymphedema (caused by HNC – head and neck cancer) as stated by “Supportive Care in Cancer”.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-496

Key Takeaways from Compression Therapy Market Study

  • The static compression therapy held the largest market share in 2019 and the trend is expected to continue in the forecast period (2020-2030)
  • Chronic ulcers are expected to hold more than 69% of market share in terms of revenue in 2020
  • Among all distribution channel, institutional sales is the leading segment followed by retail sales. Retail sales segment is anticipated to grow at CAGR of 6% over the forecast period
  • North America and Europe are collectively expected to hold more than 67% of revenue share in 2020 while East Asia is expected to show greater growth potential in the forecast period.“Acquisitions and launch of compression products along with increasing demand for compression therapy offering increased mobility, enhance athletic performance and safety profiles are driving the growth of global compression therapy market” says the FMI Analyst 

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-496

Expansion with Research: The Latest Trend

The compression therapy market players are onto the expansion spree to stand out.

For instance –

In May 2020, British Medical Journal published a study that stated that anti-embolism stockings are all the more effective with respect to DVT (deep vein thrombosis). This finding is bound to influence players to go for production of anti-embolism stockings in the forecast period

Avanos Medical Inc., in the year 2018, announced acquiring CoolSystems, Inc. The products post acquisition were marketed as “Game Ready”

Huntleigh Healthcare Ltd.’s IPC (Intermittent Pneumatic Compression) products under the “Hydroven” brand are a noteworthy addition to vascular assessment systems

Key Participant Insights

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of diabetes, rising geriatric population globally and adoption of advanced compression therapy systems which can be used as bi-layer and multi-layer for conventional treatment option. In addition to this, strict guidelines limits the design space for potential conceptual ideas and availability of alternate therapies has augmented the sales of compression products.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-496

The key market players covered by FMI include:

Paul Hartmann AG, Sigvaris AG, Cardinal Health Inc. and 3M Health Care Ltd. consolidating their positions through mergers, acquisitions and new product launches.

Key Segment

Product Type

  • Pneumatic Compression Therapy
  • Non-Segmented Pneumatic Compression Pumps
  • Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Upper Pneumatic Compression Sleeves
  • Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Segmented Pneumatic Compression Pumps without Gradient
  • Static Compression Therapy
  • Anti-Embolism Stockings
  • Compression Bandages
  • Compression Garments
  • Lower Compression Garments
  • Upper Compression Garments

Indication

  • Chronic Ulcers
  • Venous Leg Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Non-Healing Surgical Wounds
  • Traumatic Wounds
  • Burn Cases

Distribution Channel

  • Institutional Sales
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Nursing Facilities
  • Retail Sales
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

High Flow Nasal Cannula Market Size is forecast to be worth US$ 17.7 Bn by 2030 | FMI

[250 Pages] Market research company Future Market Insights’ projections on the high flow nasal cannula market Size reveal that the market is slated to be valued at ~US$ 18 Bn by 2030. Technological advancements by key market players are also anticipated to burgeon the high-flow nasal cannula market. Moreover, clinical trials for evaluating new application areas shall open up new avenues for the market. According to the Global Burden of Disease Study, 2013, around 300 million people suffered from COPD during that year. This is attributed to growing addiction for smoking, deteriorating air quality and rising pollution across the globe. The prevalence of respiratory disorders will further boost market prospects.

Growing prevalence of respiratory disorders have led to an increase in the uptake of high-flow nasal cannula (HFNC) devices. The Center for Disease Control and Prevention (CDC) acknowledges the high-flow nasal cannula oxygenation therapy as a standard recommended therapy across the United States, especially during the COVID-19 pandemic.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11269

Following this development, healthcare providers are facilitating extensive research on how to better integrate this technology in providing relief for severely infected patients. In the pre-COVID-19 scenario, HFNC was being administered to patients with acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). These conditions were responsible for a majority of respiratory casualties.

Such extensive applications to correct respiratory anomalies is anticipated to sustain the market demand for HFNC treatment solutions and devices throughout the forecast period.

“Rising incidence of respiratory problems is anticipated to steer the high-flow nasal cannula market towards a positive growth trajectory. Moreover, the coronavirus pandemic is anticipated to leverage market prospects, owing to its suitability in oxygen delivery to patients,” opines an FMI analyst.

Key Takeaways from FMI’s High Flow Nasal Cannula Market Report

  • North America and Europe shall capture half of the HFNC market
  • E-commerce to be the most widely used channels for HFNC device delivery due to preference for contactless transactions
  • Homecare settings to extensively use HFNC treatment devices
  • Infant bronchitis and pneumocephalus to generate fertile ground for HFNC treatment during 2020-2030
  • Single-use nasal cannulas gain traction during the COVID-19 crisis
  • High flow nasal cannula market shall expand at over 12% CAGR in 2020

For information on the research approach used in the report, request methodology@ https://www.futuremarketinsights.com/askus/rep-gb-11269

High Flow Nasal Cannula Market- Key Trends

  • Continuous product launches to flood the global HFNC market as vendors look to acquire a competitive edge over their rivals
  • Smooth oxygen delivery of heated, humidified oxygen at a flow rate of 60 liters per minute makes HFNC an ideal treatment method for respiratory patients
  • Partnerships and collaborations with research institutions and hospitals are increasing in order to provide treatment for severely affected COVID-19 patients

High Flow Nasal Cannula Market: Region-wise Analysis

  • Single-use HFNC devices are gaining traction across the German, Japanese and English markets respectively
  • The United States market shall expand at over 10% CAGR by 2020-end
  • Growing healthcare literacy amongst the population shall propel HFNC usage in India and China
  • Japan dominates the East-Asian high flow nasal cannula market

High Flow Nasal Cannula Market: Competitive Landscape

The high flow nasal cannula market is characterized by the presence of numerous players, making the market highly fragmented. The players are capitalizing on new product launches to acquire a market foothold.

For instance, in Jan 2019, ResMed unveiled its MOBI portable oxygen concentrator across the US market to address patients suffering from chronic obstructive pulmonary disease (COPD). Later that year, in May 2019, Fisher & Paykel Healthcare Ltd. launched the Optiflow 3S nasal cannula technology.

Likewise, Teleflex launched the Hudson RCI Comfort Flo Plus Cannula which concentrates on administering oxygen to the upper airway dead space, providing a greater level of comfort.

Buy Now@ https://www.futuremarketinsights.com/checkout/11269

High Flow Nasal Cannula Market Taxonomy

Component

  • Air/Oxygen Blender
  • Active Humidifier
  • Nasal Cannulas
  • Heated Inspiratory Circuit
  • Consumables

Medical Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bronchiectasis
  • Carbon Monoxide Toxicity
  • Sleep Apnea
  • Acute Heart Failure
  • Others

End User

  • Hospitals
  • Specialty Clinics
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Homecare Settings

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Viscosupplementation Market to reach a valuation of US$ 2.89 Bn by 2030 | Get Insights FMI

According to the study, a number of broader, and industry-specific factors will drive growth in this market, which has been relatively less impacted by the sluggishness induced by COVID-19.

Global viscosuppplementation revenues are likely to reach USD 4 billion by the end of 2030, according to a new research by ESOMAR-certified firm Future Market Insights.

As per the UN, by 2050, those aged 60 and above will account for over 20% of the global population. In other words, the UN says that by 2050 around 130 Mn people will contract osteoarthritis. These numbers point towards growth in the viscosupplementation market in the forecast period.

Covid-19 Pandemic: Viscosuppplementation Market Players Consolidating their Position

The ongoing Covid-19 pandemic has compelled the market players to take a consistent path for the next two quarters. As it would take some time for the healthcare vertical to look through new product launches; the players are looking at ways to smoothen the supply chain as manpower has taken a hit.

Continuous innovations are expected to propel the growth of viscosupplementation market” says the FMI analyst

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

Key Takeaways of Viscosupplementation Market Study

  • Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
  • Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
  • North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

New Product Development to be the Torchbearer

The market players are into the innovation mode to strengthen their foothold in the viscosupplementation market. This competitive landscape is all set to create ripples all across the market. Some of the innovations are:

  • Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
  • Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
  • Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9509

Want more insights?

Viscosupplementation market, a new study from Future Market Insights, opines on the viscosupplementation from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of; product types (single injection viscosupplementation, three injection viscosupplementation, and five injection viscosupplementation), application (knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and others such as elbow and ankle joint osteoarthritis), and end user (hospitals, ambulatory surgical centers, orthopedic clinics, retail pharmacies, and online sales) across seven prominent regions.

Viscosupplementation Market: Segmentation

The global viscosupplementation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

Application

  • Knee Oseteoarthritis
  • Hip Oseteoarthritis
  • Shoulder Oseteoarthritis
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Electronic Stethoscope Market is projected to reach a valuation around US$ 259 Million in 2022 | FMI

[263 Pages Report] Up from nearly half a million units sold in 2018, the global sales of electronic stethoscopes will observe a robust 7.2% growth in 2022. The electronic stethoscopes market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029.

Key Manufacturers Continue to Strategize on New Product Launches in Electronic Stethoscopes Landscape

Almost 2/5th of total adoption of electronic stethoscopes is registered at hospitals, the report underscores that there has been significant adoption by medical institutes in the recent past. In the next few years, medical institutes and ambulatory surgical centers are likely to create multiple opportunities for manufacturers of electronic stethoscopes.

More than half of the overall sales is accounted by amplifying electronic stethoscopes, as indicated by FMI’s analysis. While amplifying electronic stethoscopes provide results as accurate as digitizing electronic stethoscopes, the latter are associated with high maintenance owing to the presence of multiple electronic components. Amplifying electronic stethoscopes are thus expected to observe significant growth in revenue over the course of coming years.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-9457

According to the report, the market attractiveness of amplifying stethoscopes is strongly backed by the increasing number of launches of new electronic stethoscopes by a number of small- and medium-sized companies. Electronic stethoscopes are rapidly replacing conventional variants across developed countries, predominantly owing to accelerated regulatory approvals.

  • eKuore had launched the first wireless stethoscope for medical use.
  • Eko had launched the first Android–connected digital stethoscope.
  • In April 2018, Steth IO launched a digital smartphone-enabled stethoscope.

According to the report, approximately 60% of the electronic stethoscopes that are sold are enabled with Bluetooth technology and an integrated chest piece system. The former is however poised to witness a higher rate of adoption over the coming years.

North America Continues to Lead the Global Market for Electronic Stethoscopes

North America holds a considerable revenue share in the electronic stethoscopes market. With advancements in technology and the presence of a large number of healthcare facilities, electronic stethoscopes are being widely used in the region. Their ability to provide amplified sound output as well as reduce external sound makes it easy for medical professionals to detect sounds and provide proper treatment to patients.

FMI’s study has profiled some of the key companies operating in the global electronic stethoscopes market, including Eko Devices, eKuore, GlobalMed, 3M, Welch Allyn, Ambisea Technology Corp., Meditech Equipment Co., Ltd, HD Medical, Thinklabs, ADInstruments, and Cardionics Inc.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9457

Electronic Stethoscope Market by Category Product: 

  • Amplifying Stethoscopes
  • Digitizing Stethoscopes

End User:

  • Hospitals
  • Clinics
  • Medical Institutes
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Medical Camps
  • Catheterization Laboratories

Application:

  • Integrated Chest-Piece System
  • Wireless Transmission System (Bluetooth)
  • Integrated Receiver Head-Piece System
  • Other

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Tattoo Removal Lasers Market is projected to increase from a valuation of US$ 235.2 Million in 2022

[271 Pages] According to the latest research by Future Market Insights (FMI), the tattoo removal lasers market closed in on US$ 179 million in 2018. The revenue growth of tattoo removal lasers market has been estimated at a promising rate over the course of coming years. While over 7 in 10 patients prefer aesthetic clinics for the procedure of tattoo removal lasers, market value share of tattoo studios is likely to expand in coming years, as per FMI’s analysis.

Tattoo removal lasers have been incorporating the latest laser technologies specific to tattoo removal procedures. Constant developments in the tattoo removal lasers landscape, increase in product penetration across different regions, and increasing government support for R&D of innovative tattoo removal lasers will remain key demand determinants in tattoo removal lasers market.

Several new technologies have been contributing to the revenue growth of tattoo removal lasers market. However, picosecond tattoo removal lasers are extremely expensive. A combination of wavelengths has been in high demand for tattoo removal. For instance, according to a research study conducted on five patients by the Laser Health Academy, better clearance was achieved with a combination of 1,550 nm non-ablative fractional laser+YAG laser as compared to other tattoo removal lasers. The combination of YAG+YAG also resulted in shorter recovery time.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2013

According to research studies conducted on tattoo removal lasers, a combination of QS Nd: YAG (1064 nm) and CO2 lasers for tattoo removal also resulted in a significantly high improvement on the combination side for Indian skin. Combination of tattoo removal techniques is being perceived as more effective than only Q-S tattoo removal lasers, as the former reduces the need for multiple sessions.

Moreover, combination tattoo removal lasers have not only reduced the number of sessions required, but also cut costs and reduced adverse effects such as hyper-pigmentation, long-going inflammatory responses, and bulla formation. Extensive research on the efficacy of these combination tattoo removal lasers are warranted, specifically considering the high patient demand for tattoo clearance. Thus, the high demand for combination tattoo removal lasers has consistently driven the tattoo removal lasers market.

However, tattoo removal lasers work differently on different skin types, which may involve multiple adverse effects. Tattoo removal lasers that involve Q-switched also require eye protection for the prevention of retinal damage. Q-switched ruby tattoo removal lasers are linked with high clearance rates but are also contradictory because of the high incidence of prolonged hypopigmentation. Such adverse effects of tattoo removal lasers will remain are expected to hamper the growth of the tattoo removal lasers market during the forecast period.

The tattoo removal lasers market report tracks some of the key companies operating in the tattoo removal lasers market, which include Hologic Inc. (Cynosure), Shanghai Fosun Pharmaceutical(Group)Co., Ltd. (Alma Lasers), Cutera,  Syneron® Medical Ltd., Fotona d.o.o., LUTRONIC, Lumenis, El.En. S.p.A. (Asclepion Laser Technologies GmbH), and Lynton Lasers.

Some of the commonplace complications that result post tattoo removal lasers treatment include prolonged erythema, hyperpigmentation, hypertrophic scar formation, and disseminated infection. On the other side, complications associated with fractional lasers include transient pigmentary changes, mild fibrosis, and hypopigmentation. Though most of the adverse effects associated with tattoo removal lasers can be cured within a short span of time, some of them may lead to serious complications in terms of skin texture and pigmentation.

Key Segment Key Segments of Tattoo Removal Lasers Industry Survey

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2013

Tattoo Removal Lasers Market by Product:

  • Q-Switched Tattoo Removal Lasers
    • Q-Switched Nd:YAG
    • Ruby
    • Alexandrite Tattoo Removal Lasers
  • Picosecond Tattoo Removal Lasers
  • Combination Tattoo Removal Lasers

Tattoo Removal Lasers Market by End Use:

  • Aesthetic Clinics
  • Tattoo Studios

Tattoo Removal Lasers Market by Region:

  • North America Tattoo Removal Lasers Market
  • Latin America Tattoo Removal Lasers Market
  • Europe Tattoo Removal Lasers Market
  • East Asia Tattoo Removal Lasers Market
  • South Asia & Pacific Tattoo Removal Lasers Market
  • Middle East & Africa (MEA) Tattoo Removal Lasers Market

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2013

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/